Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Akt
Most Correlated Studies
- CD8-positive melanoma-infiltrating lymphocytes treated with AKT inhibitor VIII (AKTi-1-2)
- T helper D10 cells time course TCR activation in the presence of Akt inhibition
- PDK1 null and Akt inhibitor treated cytotoxic T-lymphocyte expression data
- Breast adenocarcinoma MCF7 and colon carcinoma HCT116 cells treated w/ small molecule AKT inhibitor
- L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
Most Relevant Literature
- Activity-induced synaptic structural modifications by Akt.
- A multi-layered network model identifies Akt1 as a common modulator of neurodegeneration.
- Identification of XAF1 as an endogenous AKT inhibitor.
- Redundant roles of AKT1 and AKT2 in fertility, estrous cyclicity and endometrial gland development.
- Integrated analyses of 5 mC, 5hmC methylation and gene expression reveal pathology-associated AKT3 g…
Most Relevant Clinical Trials
- Autonomic Phenotype Before and After Akt Inhibition
- Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma
- Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Ca…
- Safety, Pharmacokinetics (PK) of AKT and MEK Combination
- Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
